Trial Profile
A phase III trial of revamilast in patients with asthma or rheumatoid arthritis.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 12 Aug 2011
Price :
$35
*
At a glance
- Drugs Revamilast (Primary)
- Indications Asthma; Rheumatoid arthritis
- Focus Registrational; Therapeutic Use
- Sponsors Glenmark Pharmaceuticals Ltd
- 10 Aug 2011 New trial record